Recent evidence suggested that the PNPLA3 I148M variant might be associated with a reduction in the estimated glomerular filtration rate (eGFR) or CKD development irrespective of common renal risk factors and presence or severity of NAFLD in both adults and children [17,18,19]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.